MX9201711A - Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih. - Google Patents

Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih.

Info

Publication number: MX9201711A
Authority: MX; Mexico
Prior art keywords: delay; patient; appearance; reduce; hiv infection
Prior art date: 1991-04-16

Application number

MX9201711A

Other languages

English (en)

Inventor

William A Carter

Original Assignee

Hem Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-16

Filing date

1992-04-13

Publication date

1992-10-01

1992-04-13 Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp

1992-10-01 Publication of MX9201711A publication Critical patent/MX9201711A/es

Links

208000031886 HIV Infections Diseases 0.000 title 1
208000037357 HIV infectious disease Diseases 0.000 title 1
VZQXUWKZDSEQRR-UHFFFAOYSA-N Nucleosid Natural products C12=NC(SC)=NC(NCC=C(C)C)=C2N=CN1C1OC(CO)C(O)C1O VZQXUWKZDSEQRR-UHFFFAOYSA-N 0.000 title 1
241000700605 Viruses Species 0.000 title 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
AIDS & HIV (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

MX9201711A 1991-04-16 1992-04-13 Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih. MX9201711A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US68620091A	1991-04-16	1991-04-16

Publications (1)

Publication Number	Publication Date
MX9201711A true MX9201711A (es)	1992-10-01

Family

ID=24755338

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9201711A MX9201711A (es)	1991-04-16	1992-04-13	Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih.

Country Status (10)

Country	Link
EP (1)	EP0581906A4 (es)
JP (1)	JPH06507624A (es)
CN (1)	CN1082819C (es)
AU (1)	AU671800B2 (es)
CA (1)	CA2102221A1 (es)
IE (1)	IE920873A1 (es)
MX (1)	MX9201711A (es)
PT (1)	PT100340A (es)
WO (1)	WO1992018004A1 (es)
ZA (1)	ZA922755B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4820696A (en) *	1985-08-26	1989-04-11	Hem Research, Inc.	Modulation of aids virus-related events by double-stranded RNAS
US4795744A (en) *	1986-07-17	1989-01-03	Hem Research, Inc.	Modulation of AIDS virus-related events by double-stranded RNAS
US4945082A (en) *	1985-08-26	1990-07-31	Hem Research, Inc.	Controlled dsRNA therapy for human viral infections
US4950652A (en) *	1987-03-23	1990-08-21	Hem Research, Inc.	dsRNAs for combination therapy in the treatment of viral diseases

1992
- 1992-03-12 AU AU18718/92A patent/AU671800B2/en not_active Ceased
- 1992-03-12 CA CA002102221A patent/CA2102221A1/en not_active Abandoned
- 1992-03-12 JP JP4510192A patent/JPH06507624A/ja active Pending
- 1992-03-12 WO PCT/US1992/001972 patent/WO1992018004A1/en not_active Ceased
- 1992-03-12 EP EP92917298A patent/EP0581906A4/en not_active Withdrawn
- 1992-03-19 IE IE087392A patent/IE920873A1/en unknown
- 1992-03-20 ZA ZA922755A patent/ZA922755B/xx unknown
- 1992-04-03 PT PT100340A patent/PT100340A/pt not_active Application Discontinuation
- 1992-04-06 CN CN92102227A patent/CN1082819C/zh not_active Expired - Fee Related
- 1992-04-13 MX MX9201711A patent/MX9201711A/es unknown

Also Published As

Publication number	Publication date
IE920873A1 (en)	1992-10-21
AU1871892A (en)	1992-11-17
PT100340A (pt)	1993-07-30
WO1992018004A1 (en)	1992-10-29
CA2102221A1 (en)	1992-10-17
AU671800B2 (en)	1996-09-12
CN1068035A (zh)	1993-01-20
CN1082819C (zh)	2002-04-17
JPH06507624A (ja)	1994-09-01
EP0581906A1 (en)	1994-02-09
ZA922755B (en)	1993-04-28
EP0581906A4 (en)	1997-07-23

Similar Documents

Publication	Publication Date	Title
ES2125233T3 (es)	1999-03-01	Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
ES2187530T3 (es)	2003-06-16	Peptidos para reducir respuestas de linfocito t ctitotoxicos al virus de la hepatitis b.
DE68920915D1 (de)	1995-03-16	Extraktion und Reinigung einer Antigerinnungssubstanz aus den südamerikanischen Blutegeln Haementeria ghilianii.
AR242900A1 (es)	1993-06-30	Estructura absorbente que tiene un lado frontal al cuerpo y un lado frontal a la prenda.
IT1219811B (it)	1990-05-24	Derivati peptidici,loro preparazione e loro impiego come medicamenti
SE9602931D0 (sv)	1996-08-06	New medicinal use
MX9300358A (es)	1994-01-31	Articulo absorbente que tiene centro resilente.
WO1993017651A3 (de)	1993-11-25	Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
FI881305A7 (fi)	1988-09-24	Ihmisen virusinfektioiden käsittely dsRNA:n ja virusinhibiittorien yhdistelmällä.
MX9300550A (es)	1993-09-01	Estructura de fibra absorbente.
FI930577A7 (fi)	1993-03-24	HIV-infektion rokote ja hoitomenetelmä
ZA936592B (en)	1994-06-10	Nutrition for persons infected with human immunodeficiency virus
FR2669346B1 (fr)	1995-07-21	Vaccin a poxvirus recombinant contre le virus de la rougeole.
ES2053953T3 (es)	1994-08-01	Uso de fracciones de heparina o fragmentos de heparina.
DE68910577D1 (de)	1993-12-16	Mittel gegen den AIDS-Virus.
ITVR940096A0 (it)	1994-11-30	Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
ES2181502T3 (es)	2003-02-16	Tratamiento de la infeccion de hepatitis b con timosina alfa 1 y lamivudina.
ES1016092Y (es)	1992-05-01	Depresor anatomico lingual desechable y esteril, para la exploracion del istmo de las fauces y la faringe.
FI890116A0 (fi)	1989-01-10	Icke-reverterande rna-virus.
DK720588D0 (da)	1988-12-23	Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme
FI881123L (fi)	1988-09-13	Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
MX9700044A (es)	1997-04-30	Combinacion triple anti-virus de inmunodeficiencia humana.
ES2162862T3 (es)	2002-01-16	Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ES2160927T3 (es)	2001-11-16	Composiciones farmaceuticas que comprenden interferon alfa humano natural.
FI891917A7 (fi)	1989-10-26	HIV:n rekombinantti-GAG-prekursori, tuote, menetelmä ja käyttö AIDS-rokotteena